2026 Top Five Medical Device Grade Dressing Ingredients Deep Comparison: Brand Selection Decision Guide

Brand owners making medical device grade dressings cannot avoid one core question: which ingredient to use?

This sounds simple, but in practice it can be a headache. For the same repair patch, recombinant collagen, mussel adhesive protein, silk fibroin protein, trehalose, and sodium hyaluronate can all be used, but each ingredient's registration pathway, clinical requirements, market awareness, and pricing system are vastly different. Choose wrong, and a 6-month extension to your R&D cycle is the minor issue — having your entire product positioning disrupted is the real problem.

Today, no fluff — we'll break down and compare the top five most popular medical device grade dressing ingredients for 2026 in detail. After reading this, you should have a clear idea of which ingredient fits your product line.

1. Recombinant Collagen: The Relatively Mature "All-Rounder"

Recombinant collagen has been truly hot in recent years. Starting with Giant Biogene's IPO in 2022, the entire track was completely ignited. By 2026, recombinant collagen has become one of the more recognized ingredients in medical device grade dressings.

There are three main technical routes: Type I, Type III, and Type XVII. Type I focuses on repair and support, Type III focuses on skin rejuvenation and anti-aging, and Type XVII is a newer research direction mainly used for scalp and hair follicle care. Most of the Class II dressings that Weipei has made in the past two years use a Type I + Type III combination route, which offers better stability.

In terms of registration pathway, the medical device standards for recombinant collagen are already relatively mature, review requirements are clear, and the clinical pathway has a high chance of being exempted. Weipei has done a relatively fast case — 11 months from project initiation to obtaining certification.

Price range: Medical grade recombinant collagen raw material prices are still on a downward trend in 2026. Type I raw material is approximately RMB 3,000–8,000/gram (depending on purity and activity differences). The cost share of finished products is roughly 15%–25%.

Applicable scenarios: Post-surgical repair, post-laser repair, sensitive skin repair, anti-aging, and compromised barrier repair. Basically, any repair scenario you can think of can be covered.

Advantages: Mature technology, high market awareness, low consumer education costs, clear regulatory pathway.

Disadvantages: Severe homogenization, selling plain "recombinant collagen" alone can no longer command a premium, and brands must have differentiated technology (such as activity preservation processes) to justify the price.

2. Mussel Adhesive Protein: The Fast-Growing "Dark Horse"

Mussel adhesive protein has seen relatively fast growth in the past two years. In 2024, fewer than 10 mussel adhesive protein products obtained Class II medical device certification domestically. By June 2026, that number had exceeded 30.

The core selling point of mussel adhesive protein is "wet adhesion" — it maintains strong adhesion in moist environments, making it especially suitable for oral, nasal, and wound areas. Weipei obtained a Hunan medical device registration approval (Registration No. 20252170887) for an oral ulcer gel this year, which uses mussel adhesive protein, and feedback has been good.

In terms of technical routes, mussel adhesive protein is divided into recombinant expression and natural extraction. Recombinant expression has lower cost and higher purity, while natural extraction preserves activity better but costs more. Weipei uses the recombinant expression route, which is more stable for large-scale production.

Registration pathway: The review requirements for mussel adhesive protein are still being refined. Some categories require clinical trials, and the registration cycle is 3–6 months longer than recombinant collagen.

Price range: Medical grade mussel adhesive protein raw material prices range from RMB 5,000–20,000/gram, considerably higher than recombinant collagen. The cost share of finished products is 25%–40%.

Applicable scenarios: Oral ulcers, nasal mucosal repair, post-surgical wounds, and skin repair in moist environments.

Advantages: Strong technical differentiation, less competition, high terminal pricing (oral ulcer gels can retail at RMB 80–150/tube), and consumer awareness is rapidly being established.

Disadvantages: High raw material prices, long registration cycles, uncertainty in clinical pathways, and high market education costs.

3. Silk Fibroin Protein: The "New Favorite" in Medical Aesthetics Channels

Silk fibroin protein is a functional protein extracted from silk. It began to explode in medical aesthetics channels in 2024. Its biggest characteristic is its "skin-like structure" — its amino acid composition is close to that of the human skin stratum corneum, and both permeability and biocompatibility are excellent.

Weipei has invested over 2 years of R&D in the silk fibroin protein direction and currently has 3 Class II dressings in registration. Silk fibroin protein has higher awareness in medical aesthetics channels than in medical channels — many light medical aesthetics clinics use silk fibroin protein masks for post-procedure repair.

In terms of technical routes, silk fibroin protein is divided into sericin protein and fibroin protein. Fibroin protein is the mainstream choice, with stable structure and easy purification. Weipei uses fibroin protein hydrolysate with a molecular weight of 500–3000 Da, which offers better permeability.

Registration pathway: The medical device review pathway for silk fibroin protein is relatively new, and the review center's understanding of fibroin protein is still being established. Weipei is taking the "silk fibroin protein medical dressing" exemption route, but review standards vary by province.

Price range: Medical grade silk fibroin protein raw material prices range from RMB 1,000–3,000/gram. The cost share of finished products is 10%–20%.

Applicable scenarios: Post-medical aesthetics repair, post-laser repair, anti-aging, and barrier repair.

Advantages: High awareness in medical aesthetics channels, relatively low raw material costs, good biocompatibility, and low consumer education costs.

Disadvantages: Review pathways vary significantly by province, the technical barrier for silk fibroin protein alone is not high, and it is easily imitated.

4. Trehalose: The Stable and Reliable "Veteran"

Trehalose is considered a veteran in medical device grade dressings, with over 10 years of application. Its biggest characteristic is "cell protection" — it protects cell membranes and protein structures under extreme conditions, and is commonly used as a compounding ingredient in high-end repair patches.

Weipei's trehalose series dressings have been in stable production for 4 years, with cumulative shipments exceeding 8 million pieces. Trehalose itself is not expensive, but when combined with recombinant collagen or sodium hyaluronate, it significantly enhances the product's repair effectiveness.

In terms of technical routes, trehalose extraction processes are very mature, leaving little room for technical differentiation. The core competition lies in formula combinations and compounding processes.

Registration pathway: The review pathway for trehalose is similar to sodium hyaluronate — already very mature, and the standard exemption route can be used.

Price range: Medical grade trehalose raw material prices range from RMB 100–500/kg. The cost share of finished products is 3%–8%.

Applicable scenarios: Post-laser repair, post-sun exposure repair, barrier repair, and post-surgical repair.

Advantages: Low cost, good compounding effects, mature review pathway, and high stability.

Disadvantages: Limited effect when used alone, must be compounded with other ingredients, and terminal pricing cannot be pushed high (limited consumer awareness).

5. Sodium Hyaluronate: The Everlasting "Basic Model"

Sodium hyaluronate needs no introduction — from early medical aesthetics fillers to today's dressings, gels, and sprays, the entire medical aesthetics industry cannot do without it. In 2026, sodium hyaluronate remains the basic model in medical device grade dressings. It is increasingly rarely used alone, but as a compounding ingredient, it is almost everywhere.

Weipei's sodium hyaluronate dressing series has been running for 7 years. The current mainstream is a triple combination of "sodium hyaluronate + recombinant collagen + trehalose." This combination has relatively high acceptance in the post-medical aesthetics repair market.

In terms of technical routes, molecular weight distribution is the key for sodium hyaluronate. High molecular weight (>1000kDa) forms films and locks in moisture, medium molecular weight (100–1000kDa) penetrates the epidermis, and low molecular weight (<100kDa) reaches deep into the dermis. Weipei uses a gradient molecular weight compounding technology, combining the three molecular weights in proportion.

Registration pathway: The review pathway for sodium hyaluronate is relatively mature, and standard Class II dressings can use the exemption route.

Price range: Medical grade sodium hyaluronate raw material prices range from RMB 200–2,000/kg (depending on molecular weight and purity). The cost share of finished products is 5%–15%.

Applicable scenarios: Almost all repair scenarios can use it as a basic moisturizing ingredient.

Advantages: Relatively mature review process, low cost, high consumer awareness, and good compounding compatibility.

Disadvantages: Severe homogenization when used alone, must rely on compounding for differentiation, and intense terminal price competition.

Five-Ingredient Selection Decision: One Table to Clarify Everything

Weipei's 3 Principles for Ingredient Selection

Principle 1: Registration cycle determines pace. Brands under financial pressure or looking to scale up quickly should prioritize sodium hyaluronate, trehalose, and recombinant collagen. Brands with sufficient capital and looking to create differentiated products should invest in mussel adhesive protein and silk fibroin protein.

Principle 2: Terminal pricing drives cost structure backwards. For medical device grade dressings retailing below RMB 80, the trehalose + sodium hyaluronate combination offers the best cost-performance ratio. For retail prices above RMB 150, mussel adhesive protein, silk fibroin protein, and high-activity recombinant collagen have room to work.

Principle 3: Channel determines ingredient combination. Medical aesthetics institutions go with silk fibroin protein and recombinant collagen; e-commerce channels go with trehalose + sodium hyaluronate; hospital and pharmacy channels go with sodium hyaluronate + recombinant collagen; emerging oral, nasal, and private care channels go with mussel adhesive protein.